首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Alzheimers & dementia-translational research & clinical interventions

缩写:

ISSN:N/A

e-ISSN:2352-8737

IF/分区:7.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1069
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Bruna Bellaver,Guilherme Povala,Marco Antônio De Bastiani et al. Bruna Bellaver et al.
Introduction: Neuroinflammation is increasingly recognized as a key contributor to Alzheimer's disease (AD) progression, with distinct responses linked to amyloid beta (Aβ) and tau pathology. Two detrimental waves of neu...
Pablo Martinez-Amezcua,Wuyang Zhang,Erin E Dooley et al. Pablo Martinez-Amezcua et al.
Introduction: The relationship between daily steps and brain health is relatively underexplored, with inconsistent findings regarding the number of steps that confer cognitive benefits. ...
Kyra O&#x;Brien,Cameron Coykendall,Kristin Harkins et al. Kyra O&#x;Brien et al.
Introduction: Blood-based Alzheimer's disease (AD) biomarkers are increasingly used in clinical care, but there are few real-world studies of their clinical utility. We evaluated the impact of plasma phosphorylated tau at...
Xiaowen Zhou,Guangshi Zhang,Qili Hu et al. Xiaowen Zhou et al.
Introduction: Excessive daytime sleepiness (EDS) is common in community-dwelling older adults, but its association with long-term incident dementia remains unclear. The roles of Alzheimer's disease (AD) pathology and vasc...
Elie Matar,Simon R White,John-Paul Taylor et al. Elie Matar et al.
Introduction: Dementia with Lewy bodies (DLB) or Parkinson's disease dementia (PDD), collectively termed Lewy body dementia (LBD), show heterogenous progression across cognitive, motor, and neuropsychiatric symptom domain...
Mai Othman,Eman Khedr,Shimaa Heikal et al. Mai Othman et al.
Introduction: The apolipoprotein E (APOE) gene is the strongest known genetic risk factor for late-onset Alzheimer's disease (AD), particularly the ε4 allele. Evidence suggests that women carrying at least one APOE ε4 a...
Men Thi Hoang,Alina Mona Zenker,Sanjib Saha et al. Men Thi Hoang et al.
This review aims to appraise and summarize the best available evidence from economic evaluations (EEs) of strategies targeting populations prior to a diagnosis of dementia. A comprehensive search was conducted in EMBASE, PubMed, EconLit, We...
Tuyet Thao Nguyen,Bozhidar T Chakalov,Megan Van Noord et al. Tuyet Thao Nguyen et al.
Introduction: Monoclonal antibodies (mAbs) for Alzheimer's disease (AD) represent major therapeutic advances, but their economic value is uncertain. This review narratively examines cost-effectiveness analyses (CEAs) of a...
Ahmad A Toubasi,Thuraya N Al-Sayegh Ahmad A Toubasi
Introduction: Systemic inflammation and innate immune activation have been implicated in dementia; however, prior studies were limited by small sample sizes. We conducted this study to evaluate the association between per...
Maayan Harel,Anat Leibovici,Nofar Itzhaki et al. Maayan Harel et al.
Introduction: Alzheimer's disease (AD) pathological processes begin decades before symptom onset. Early intervention in high-risk populations may be crucial for prevention. We investigated the effect of an intervention ut...